Ameriprise
TARS icon

Ameriprise’s Tarsus Pharmaceuticals TARS Stock Holding History

Ameriprise’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$600K Sell
8,551
-52
-0.6% -$3.63K ﹤0.01% 3513
2025
Q4 		$704K Sell
8,603
-40
-0.5% -$2.99K ﹤0.01% 3493
2025
Q3 		$514K Sell
8,643
-97
-1% -$4.78K ﹤0.01% 3613
2025
Q2 		$354K Sell
8,740
-50,174
-85% -$2.26M ﹤0.01% 3641
2025
Q1 		$3.03M Buy
58,914
+11,229
+24% +$555K ﹤0.01% 2665
2024
Q4 		$2.64M Buy
47,685
+8,336
+21% +$379K ﹤0.01% 2771
2024
Q3 		$1.29M Sell
39,349
-8,799
-18% -$247K ﹤0.01% 3108
2024
Q2 		$1.31M Sell
48,148
-10,219
-18% -$344K ﹤0.01% 3045
2024
Q1 		$2.12M Buy
58,367
+4,917
+9% +$145K ﹤0.01% 2840
2023
Q4 		$1.08M Buy
53,450
+145
+0.3% +$2.42K ﹤0.01% 3154
2023
Q3 		$947K Buy
53,305
+37,430
+236% +$662K ﹤0.01% 3168
2023
Q2 		$287K Buy
+15,875
New +$252K ﹤0.01% 3622

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return